Erythropoietin-induced changes in brain gene expression reveal induction of synaptic plasticity genes in experimental stroke

Mengozzi, Manuela, Cervellini, Ilaria, Villa, Pia, Erbayraktar, Zübeyde, Gökmen, Necati, Yilmaz, Osman, Erbayraktar, Serhat, Manohasandra, Mathini, Van Hummelen, Paul, Vandenabeele, Peter, Chernajovsky, Yuti, Annenkov, Alexander and Ghezzi, Pietro (2012) Erythropoietin-induced changes in brain gene expression reveal induction of synaptic plasticity genes in experimental stroke. Proceedings of the National Academy of Sciences of the United States of America, 109 (24). pp. 9617-9622. ISSN 1091-6490

Full text not available from this repository.

Abstract

Erythropoietin (EPO) is a neuroprotective cytokine in models of ischemic and nervous system injury, where it reduces neuronal apoptosis and inflammatory cytokines and increases neurogenesis and angiogenesis. EPO also improves cognition in healthy volunteers and schizophrenic patients. We studied the effect of EPO administration on the gene-expression profile in the ischemic cortex of rats after cerebral ischemia at early time points (2 and 6 h). EPO treatment up-regulated genes already increased by ischemia. Hierarchical clustering and analysis of overrepresented functional categories identified genes implicated in synaptic plasticity-Arc, BDNF, Egr1, and Egr2, of which Egr2 was the most significantly regulated. Up-regulation of Arc, BDNF, Dusp5, Egr1, Egr2, Egr4, and Nr4a3 was confirmed by quantitative PCR. We investigated the up-regulation of Egr2/Krox20 further because of its role in neuronal plasticity. Its elevation by EPO was confirmed in an independent in vivo experiment of cerebral ischemia in rats. Using the rat neuroblastoma B104, we found that wild-type cells that do not express EPO receptor (EPOR) do not respond to EPO by inducing Egr2. However, EPOR-expressing B104 cells induce Egr2 early upon incubation with EPO, indicating that Egr2 induction is a direct effect of EPO and that EPOR mediates this effect. Because these changes occur in vivo before decreased inflammatory cytokines or neuronal apoptosis is evident, these findings provide a molecular mechanism for the neuroreparative effects of cytokines and suggest a mechanism of neuroprotection by which promotion of a plastic phenotype results in decreased inflammation and neuronal death.

Item Type: Article
Keywords: neuroprotection; microarrays; ischemia-reperfusion injury; neurotrophins; early genes; neuronal cells
Schools and Departments: Brighton and Sussex Medical School > Clinical and Laboratory Investigation
Subjects: Q Science
Depositing User: Manuela Mengozzi
Date Deposited: 06 Sep 2012 08:23
Last Modified: 17 Jun 2013 08:37
URI: http://sro.sussex.ac.uk/id/eprint/40562
📧 Request an update